Posted on 22 October 2014
The field of regenerative medicine is an up and coming new approach of targeting and treating diseases, it involves the repair and restoration of previously damaged tissues or organs in the body. The regenerative medicine market was worth $16bn in 2013 and industry analysts predict that this will leap to over $60bn by 2020. The more »
Tags: deals analysis, partnering terms, regenerative medicine
Posted on 08 October 2014
Molecular diagnostics is the use of molecular biology for medical testing and clinical applications. This discipline determines how genes and proteins interact in a cell. This partnering article reflects on the recent life science trends in the molecular diagnostics technology arena.
Tags: diagnostics, molecular, partnering terms, pharma partnering
Posted on 08 October 2014
The bioinformatics partnering deal trend analysis 2009 to 2014 are reviewed in this article.
Tags: bioinformatics, deal analysis, pharma deals
Posted on 07 August 2014
Monoclonal antibodies are developed to be very selective in targeting cells. This is why they have come to be an indispensable research tool in cancer treatment being able to specifically target tumor cells.
Tags: big pharma, cancer, monoclonal antibodies
Posted on 06 August 2014
Recent life science trends has seen tremendous developments in new diagnostic and medical imaging techniques. Imaging tools such as CT scans, endoscopes, PET, SPECT, ultrasound and MRI are all showing promise and precise accuracy in diagnosing diseases like cancer, hospital care, cardiovascular, etc
Tags: diagnostics, life science trends, medical diagnostics
Posted on 24 July 2014
Regenerative medicine has become increasingly popular in recent years, with the number of deals announced growing steadily
Posted on 21 July 2014
A recent market research analysis of monoclonal antibody partnering has shown a high interest in partnering deals involving monoclonal antibody technology in the past few years
Tags: industry analysis, market research analysis, market research intelligence, monoclonal antibodies
Posted on 08 July 2014
Diagnostics are subject to numerous partnering deals every year. Here we provide a review of recent life science trends in deal making activity
Tags: diagnostics, industry analysis, life science trends, pharma partnering
Posted on 07 July 2014
Industry trends suggest that vaccine research and development is an increasingly active component of healthcare business development. In recent years there has been a significant increase in vaccine partnering and M&A activity.
Tags: big pharma, partnering, points of view, vaccines
Posted on 02 June 2014
Industry trends suggest that infectious vaccines research and development is an increasingly active component of healthcare business development. The last decade has witnessed a significant number of infectious vaccines partnering and M&A activity
Tags: industry analysis, industry trends, licensing, market research analysis, pharma partners